Feature
April 7, 2014 — A first-ever randomized head-to-head comparison of two devices commonly used to treat aortic stenosis finds balloon-expandable transcatheter valves (such as the Edwards Sapien) result in more successful procedures and relieve symptoms more frequently than self-expanding valves (e.g., Medtronic CoreValve), according to research presented at ACC.14.
April 07, 2014
Feature
April 7, 2014 — Strategies aimed at reducing the number of patients with heart failure and other cardiovascular conditions who find themselves back in the hospital after discharge were identified in six new studies presented at the American College of Cardiology (ACC) 63rd annual scientific session.
April 07, 2014
Feature | Hypertension | Dave Fornell
A major disappointment earlier this year was the announcement by Medtronic that its renal denervation system failed to meet its primary endpoint for efficacy in the U.S. SYMPLICITY HTN-3 trial. This trial data was presented to a packed, standing-room only crowd of several thousand cardiologists at the American College of Cardiology (ACC) 63rd annual scientific session in March. These attendees also sought more information and a glimmer of hope for the technology at the presentation of data from the Global SYMPLICITY registry and numerous sessions on renal denervation technology.
April 04, 2014Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature
Head-to-Head Study Reports Patient Comfort With Iodixanol, Iopamidol During Peripheral Arteriography
GE Healthcare announced results from a new clinical study, which showed that patients receiving iodixanol (Visipaque) 320mg I/ml reported less discomfort, characterized by heat or cold sensation or pain upon injection, than patients receiving iopamidol (Isovue) 370 mg I/ml during peripheral arteriography.
April 04, 2014
News
A new stent covered with biodegradable coating continues to show statistical equivalence to Japan’s market leader in cumulative second-year data and subgroup analyses, according to research from the NEXT trial presented at the American College of Cardiology’s 63rd Annual Scientific Session.
April 04, 2014
Videos | Stents Bioresorbable
Bioresorbable stent technology was one of the big interventional technologies discussed at the American College of ...
April 03, 2014Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Videos | Heart Valve Technology
The biggest late-breaking news to come out of the American College of Cardiology (ACC) 2014 meeting was from the ...
April 03, 2014
Videos | Renal Denervation
A major disappointment earlier this year was the announcement by Medtronic that its renal denervation system failed to ...
April 03, 2014
Technology
April 3, 2014 — The new app-driven Seer 1000 Holter recorder from GE Healthcare utilizes new technology to simplify Holter monitor management.
April 03, 2014Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology
April 3, 2014 — Siemens Healthcare announced the U.S. Food and Drug Administration (FDA) has cleared the Cios Alpha, a new mobile C-arm system with flat-panel detector that boasts a power output of 25 kilowatts (kW) and has a field of view (FoV) that is up to 25 percent larger than conventional C-arms.
April 03, 2014
Technology
April 2, 2014 — At the 2014 annual scientific session of the American College of Cardiology (ACC), GE Healthcare introduced a new version of its Muse ECG (electrocardiograph) management system that now allows interoperability with non-GE ECG systems.
April 02, 2014
Feature | Dave Fornell
The key trial presented at the 2014 American College of Cardiology (ACC) that will likely be the one attendees will remember “they were there for” in the years to come was data showing transcatheter aortic valve replacement (TAVR) outperformed surgical valve replacement. The late-breaking presentation of the CoreValve U.S. pivotal high-risk trial showed the Medtronic self-expanding CoreValve device had a 26 percent survival benefit above the surgical valve implant patients.
April 02, 2014Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Technology
April 2, 2014 — At the 63rd annual scientific session of the American College of Cardiology (ACC), Esaote premiered its new CrystaLine imaging technology that improves ultrasound’s diagnostic efficiency by enhancing image clarity and providing clinicians the ability to personalize image quality for each patient.
April 02, 2014Feature
Statins are associated with a significant improvement in erectile function, a fact researchers hope will encourage men who need statins to reduce their risk of heart attack to take them, according to research to be presented at the American College of Cardiology’s 63rd Annual Scientific Session.
April 02, 2014
Technology
Acist Medical Systems Inc. announced at the American College of Cardiology's 63rd Annual Scientific Session in Washington, D.C., the global introduction of the new Acist|RXi Rapid Exchange FFR System — the world's first rapid exchange FFR system.
April 02, 2014© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now